Merus' MeMo-derived common light chain antibodies receive European patent pharmabiz.com Saturday, October 26, 2013, 16:00 Hrs [IST]. Merus BV, a biopharmaceutical company focusing on innovative antibody therapeutics, has received a European patent on its MeMo transgenic mouse for the generation of common light chain human antibodies. |
